Histone lactylation drives oncogenesis by facilitating m<sup>6</sup>A reader protein YTHDF2 expression in ocular melanoma.
Yu J, Chai P, Xie M, Ge S, Ruan J, Fan X, Jia R. · 2021
Read Histone lactylation drives oncogenesis by facilitating m<sup>6</sup>A reader protein YTHDF2 expression in ocular melanoma. by Yu J, Chai P, Xie M, Ge S, Ruan J, Fan X, Jia R. (2021) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc7962360.txt.
Description
Yu and co-authors report a laboratory study of a chemical mark that drives eye melanoma. The mark is histone lactylation, a change to the proteins that package DNA. It rises under metabolic stress and can switch genes on. Its role in tumour growth was unclear. The team studied it in ocular melanoma, a cancer of the eye.
The mark ran high in the tumours and tracked with poor outcomes. Fixing the abnormal marking slowed the cancer in dishes and in animals. The mark worked by raising a gene called YTHDF2. That gene's product reads a second mark on RNA and destroys two key messages, PER1 and TP53. Losing those guards sped the tumour's growth. The authors name the marking pathway as a fresh drug target. The work also links two kinds of chemical marks into one chain.
Catalog record
| CREATOR | Yu J, Chai P, Xie M, Ge S, Ruan J, Fan X, Jia R. |
|---|---|
| YEAR | 2021 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 57 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |